Skip to main content
SpringerLink
Log in

Sentinel Lymph Node Mapping for Thick (≥4-mm) Melanoma: Should We Be Doing It?

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Thick (≥4-mm) primary melanomas are believed to be associated with a high incidence of occult distant metastases. The use of sentinel lymph node (SLN) mapping and biopsy in the treatment lesions has been questioned.

Methods: A retrospective review of a computerized database identified 114 patients who underwent successful SLN mapping and biopsy from January 1, 1994, to December 31, 1999. Records were reviewed for clinicopathologic features of the patients and their tumors. Survival curves were constructed from Kaplan-Meier estimates and analyzed with log-rank tests and Cox proportional hazards modeling.

Results: There were 75 men and 39 women with a mean age of 57 years (range, 24–85 years). The primary tumor sites were head and neck (n = 29; 25.4%), trunk (n = 44; 38.6%), and extremities (n = 41; 36%). Tumor thickness ranged from 4 to 17 mm (median, 5.2 mm; mean, 6.3 mm). Ulceration was present in 40 (35.1%) tumors. Thirty-seven patients (32.5%) had a positive SLN biopsy, and 18 of these patients (48.6%) had a single tumor-positive lymph node after dissection. The mean follow-up was 37.8 months. The overall 3-year survival for SLN-negative patients was 82%, versus 57% for SLN-positive patients (P = .006). Lymph node status and tumor ulceration were independent predictors of overall survival in multivariate Cox regression analysis.

Conclusions:The pathologic status of the SLN in patients with thick melanomas is a strong independent prognostic factor for survival, and SLN mapping should be routinely performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622–34.

    PubMed  CAS  Google Scholar 

  2. Mansfield PF, Lee JE, Balch CM. Cutaneous melanoma: current practice and surgical controversies. Curr Probl Surg 1994;31:253–374.

    Article  PubMed  CAS  Google Scholar 

  3. Kim SH, Garcia C, Rodriguez J, et al. Prognosis of thick cutaneous melanoma. J Am Coll Surg 1999;188:241–7.

    Article  PubMed  CAS  Google Scholar 

  4. Gershenwald JE, Mansfield PF, Lee JE, et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol 2000;7:160–5.

    Article  PubMed  CAS  Google Scholar 

  5. Clary BM, Brady MS, Lewis JJ, et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001;233:250–8.

    Article  PubMed  CAS  Google Scholar 

  6. Essner R. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin Oncol 1997;24(1 Suppl 4):S8–10.

    CAS  Google Scholar 

  7. Pijpers R, Borgstein PJ, Meijer S, et al. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997;21:788–92; discussion 793.

    Article  PubMed  CAS  Google Scholar 

  8. Murray DR, Carlson GW, Greenlee R, et al. Surgical management of malignant melanoma using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy: the Emory experience. Am Surg 2000;66:763–7.

    PubMed  CAS  Google Scholar 

  9. Coit D, Sauven P, Brennan M. Prognosis of thick cutaneous melanoma of the trunk and extremity. Arch Surg 1990;125:322–6.

    PubMed  CAS  Google Scholar 

  10. Heaton KM, Sussman JJ, Gershenwald JE, et al. Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma. Ann Surg Oncol 1998;5:322–8.

    Article  PubMed  CAS  Google Scholar 

  11. Schneebaum S, Briele HA, Walker MJ, et al. Cutaneous thick melanoma. Prognosis and treatment. Arch Surg 1987;122:707–11.

    PubMed  CAS  Google Scholar 

  12. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000;7:469–74.

    Article  PubMed  CAS  Google Scholar 

  13. Zettersten E, Sagebiel RW, Miller JR, et al. Prognostic factors in patients with thick melanoma (> 4 mm). Cancer 2002;94:1049–56.

    Article  PubMed  Google Scholar 

  14. Ferrone CR, Panageas KS, Busam K, et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol 2002;9:637–45.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Winship Cancer Institute, Emory University, Atlanta, Georgia

    Grant W. Carlson MD, Douglas R. Murray MD, Andrea Hestley BA, Charles A. Staley MD & Cynthia Cohen MD

  2. Emory University School of Medicine, Emory University, Atlanta, Georgia

    Robert H. Lyles PhD

  3. Department of Biostatistics, Rollins School of Public Health, Emory University, Atlanta, Georgia

    Grant W. Carlson MD

Authors
  1. Grant W. Carlson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Douglas R. Murray MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrea Hestley BA
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles A. Staley MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert H. Lyles PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cynthia Cohen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Grant W. Carlson MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlson, G.W., Murray, D.R., Hestley, A. et al. Sentinel Lymph Node Mapping for Thick (≥4-mm) Melanoma: Should We Be Doing It?. Ann Surg Oncol 10, 408–415 (2003). https://doi.org/10.1245/ASO.2003.03.055

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.03.055

Key Words:

Search

Navigation